| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A decisive year for the neurological community
|
The Lancet Neurology,
|
|
|
21 |
2 |
p. 103
|
artikel
|
| 2 |
Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders
|
Verschuuren, Jan JGM
|
|
|
21 |
2 |
p. 189-202
|
artikel
|
| 3 |
Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders
|
Huijbers, Maartje G
|
|
|
21 |
2 |
p. 163-175
|
artikel
|
| 4 |
Advancing research in autoimmune neuromuscular disorders
|
Sanders, Donald B
|
|
|
21 |
2 |
p. 108-110
|
artikel
|
| 5 |
A neurological journey to save lives in Haiti
|
Barthélemy, Ernest J
|
|
|
21 |
2 |
p. 124
|
artikel
|
| 6 |
Correction to Lancet Neurol 2022; 21: 42–52
|
|
|
|
21 |
2 |
p. e2
|
artikel
|
| 7 |
Daridorexant for insomnia disorder
|
Spiegelhalder, Kai
|
|
|
21 |
2 |
p. 104-105
|
artikel
|
| 8 |
Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation
|
Galimberti, Stefania
|
|
|
21 |
2 |
p. 153-162
|
artikel
|
| 9 |
Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders
|
Punga, Anna Rostedt
|
|
|
21 |
2 |
p. 176-188
|
artikel
|
| 10 |
Frailty and outcome after traumatic brain injury
|
Panza, Francesco
|
|
|
21 |
2 |
p. 107-108
|
artikel
|
| 11 |
From patients to disease: the difficult case of Alzheimer's
|
Frisoni, Giovanni B
|
|
|
21 |
2 |
p. 105-106
|
artikel
|
| 12 |
Guillain-Barré syndrome after vaccination against COVID-19
|
Chun, June Young
|
|
|
21 |
2 |
p. 117-119
|
artikel
|
| 13 |
Jeyaraj Pandian: passionate about improving stroke care in India
|
Samarasekera, Udani
|
|
|
21 |
2 |
p. 120
|
artikel
|
| 14 |
Lightning progress in child neurology in the past 20 years
|
Scheffer, Ingrid E
|
|
|
21 |
2 |
p. 111-113
|
artikel
|
| 15 |
Pimavanserin and dementia-related psychosis
|
Tariot, Pierre N
|
|
|
21 |
2 |
p. 114-115
|
artikel
|
| 16 |
Primary stroke prevention: useful thresholds?
|
Feigin, Valery L
|
|
|
21 |
2 |
p. 116
|
artikel
|
| 17 |
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
|
Mignot, Emmanuel
|
|
|
21 |
2 |
p. 125-139
|
artikel
|
| 18 |
Social determinants of neurological disease: tackling inequalities
|
Dobson, Ruth
|
|
|
21 |
2 |
p. 122-123
|
artikel
|
| 19 |
Teshamae Monteith
|
|
|
|
21 |
2 |
p. 121
|
artikel
|
| 20 |
The Bell-Magendie debate
|
Drouin, Emmanuel
|
|
|
21 |
2 |
p. 121
|
artikel
|
| 21 |
The need for a better global dementia response
|
Seeher, Katrin
|
|
|
21 |
2 |
p. 115
|
artikel
|
| 22 |
The need for a better global dementia response
|
Wallace, Lindsay
|
|
|
21 |
2 |
p. 115-116
|
artikel
|
| 23 |
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study
|
Chhatwal, Jasmeer P
|
|
|
21 |
2 |
p. 140-152
|
artikel
|
Tijdschrift beschrijving